New Immune-Boosting drug takes on tough cancers in first human trial
Disease control
Ongoing
This early-phase trial tests an experimental drug called AB248, which aims to boost the body's cancer-fighting immune cells. It is given alone or with the approved immunotherapy Keytruda to adults with advanced solid tumors like lung cancer, melanoma, or kidney cancer. The main g…
Phase: PHASE1 • Sponsor: Asher Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 26, 2026 15:50 UTC